Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > WHOSE SIDE IS THE CEO ON? US (Commons) or THEM (Cobras)?

<< Previous

Bullboard Posts

Next >>

Comment by amendison Jul 30, 2021 6:34pm

211 Views

Post# 33636024

RE:WHOSE SIDE IS THE CEO ON? US (Commons) or THEM (Cobras)?

I don't know whose side is CEO, I know for sure, He is not share holder side. Is he leave can another guy can ask to use as emergency use. with this CEO can rise money Phase 3 need 19000 Patient. We are not covet People FDA knows this guy can bully easy. Covet not end yet. I wish FDA talk give to the Public.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project